logo

Quick Facts

Share

AbbVie (ABBV) has submitted an application to the FDA seeking approval for risankizumab-rzaa or SKYRIZI, for the treatment of patients 16 years and older with moderate to severe Crohn's disease. The submission is supported by data from three phase 3 studies - ADVANCE, MOTIVATE and FORTIFY. Crohn's...

Genentech, a member of the Roche Group (RHHBY), said it presented new data from the Phase III IMpower010 study at the European Society for Medical Oncology Congress 2021 Presidential Symposium. The data reinforce the significant disease-free survival or DFS benefit offered by Tecentriq (atezolizumab)...

Pilgrim's Pride Corp. (PPC) said its board of directors has formed a special committee of independent directors to review and evaluate the unsolicited proposal received from JBS S.A. to acquire all of the outstanding shares of common stock of PPC that JBS does not currently own. The PPC board will...

Aurubis AG (AIAGY.PK, AIAGF.PK) said Aurubis Stolberg GmbH & Co. KG will gradually resume production starting November 1. The company said it will be possible to start manufacturing certain strip products in a limited production capacity starting in early November. Aurubis Stolberg is one of the leading...

Sixt SE (SIXGF.PK) said its Managing Board has significantly raised previous forecast for fiscal 2021. The company said the reasons for this revision are in particular the development of the vacation business in Europe and the USA, which is significantly above the recent expectations, the continuation...

Accenture (ACN) announced its plan to acquire Experity, a provider of cloud-based customer experience and commerce solutions. Headquartered in Sao Paulo, Brazil, Experity offers consulting, implementation, support and other related services for leading cloud-based platforms. Terms of the deal were...

Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million...

Abbott (ABT) announced FDA approval for Portico with FlexNav transcatheter aortic valve replacement system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery. Portico is a self-expanding TAVR valve with intra-annular leaflets that help provide...

Mirati Therapeutics, Inc. (MRTX) reported positive topline results from the potentially registration-enabling cohort of the phase 2 KRYSTAL-1 study, evaluating adagrasib in patients with KRAS G12C-Mutated advanced non-small cell lung cancer. In the intent-to-treat population, the study showed adagrasib...

Oncolytics Biotech Inc. (ONCY, ONC.TO) announced preclinical data demonstrating the synergistic immunotherapeutic effects of pelareorep combined with radiotherapy in a murine cancer model. Preclinical studies presented in the poster evaluated various treatment combinations of pelareorep, ionizing...

Private equity firm BlackRock Long Term Private Capital or LTPC, announced Monday that it has acquired a majority interest in Summit Companies, a leading fire and life safety service and installation company, from CI Capital Partners. BlackRock LTPC will partner with Summit's management team to drive...

Bristol Myers Squibb (BMY) said FDA has accepted for priority review the Biologics License Application for relatlimab and nivolumab fixed-dose combination in the treatment of adult and pediatric patients with unresectable or metastatic melanoma. The BLA submission was based on the efficacy and safety...

Omnicom Group Inc. (OMC) today announced it has agreed to acquire antoni, a Berlin-based, digitally-native advertising agency. antoni is one of the most innovative and creative advertising agencies in Europe. Since its launch in 2015 with its founding client, Mercedes-Benz, antoni has grown to more...

Boston Scientific Corp. (BSX) said that late-breaking data demonstrated improved progression-free survival in patients with metastatic colorectal cancer after treatment with boston scientific therasphere Y-90 Glass Microspheres. The company noted that the EPOCH clinical trial of the TheraSphere Y-90...

Cognyte Software Ltd. (CGNT) said its second quarter results came in ahead of its expectations. Looking forward, the company increased its annual outlook for profitability. Second quarter non-GAAP earnings per share declined to $0.17 from $0.29, last year. On average, six analysts polled by Thomson...

Follow RTT